Generic placeholder image

Cardiovascular & Hematological Agents in Medicinal Chemistry

Editor-in-Chief

ISSN (Print): 1871-5257
ISSN (Online): 1875-6182

Review Article

Tacrolimus and Cyclosporin Pharmacotherapy, Detection Methods, Cytochrome P450 Enzymes after Heart Transplantation

Author(s): Zahra Tolou-Ghamari*

Volume 22, Issue 2, 2024

Published on: 09 August, 2023

Page: [106 - 113] Pages: 8

DOI: 10.2174/1871525721666230726150021

Price: $65

conference banner
Abstract

Background: Advances in organ transplantation were made after the discovery of the pure form of cyclosporine by Dr Jean Borel in the 1970s. In fact, in clinical practice achieving a delicate balance in circulating immunosuppressive necessitate focus on the difficult task of posttransplant therapeutic drug monitoring.

Objective: The purpose of this study was to determine the pharmacologic properties of cyclosporine- tacrolimus, detection methods, and the effects on the activity of cytochrome P450 enzymes when prescribing the most efficient treatments in forms of polypharmacy for the recipients of heart transplantation.

Methods: Scientific literature on the interactions of tacrolimus and cyclosporine with human cytochrome P450 enzymes was searched using PUBMED.Gov (https://pubmed.ncbi.nlm.nih.gov/), Web of Science, and Scopus.

Results: Prescription immunosuppressive drugs based on polypharmacy accompanied by induction agents could result in hidden neurotoxicity and nephrotoxicity. A literature search shows that cyclosporine prescription with antihypertensives drugs needs close monitoring. Co-administration of tacrolimus and diltiazem or verapamil needs a decrease in the tacrolimus dose by 20-50%. Vigilant attention to the lowest possible statin dose is needed when coadministered with fluvastatin or pravastatin. Polypharmacy based on ticlopidine, clopidogrel, and cyclosporine or tacrolimus needs monitoring of immunosuppressive drug levels for several months. A prescription with clotrimazole or fluconazole needs close monitoring, and itraconazole or ketoconazole needs to reduce the initial dose by 50%. Combination with nefazodone needs to be avoided, and alternative drugs such as sertraline or citalopram could be prescribed in addition to further monitoring consideration. In prescription with phenytoin, the bound and free phenytoin levels need close monitoring.

Conclusion: Polypharmacy based on tacrolimus or cyclosporine needs vigilant therapeutic drug monitoring due to the cytochrome P450 enzymes associated with biochemical variables in metabolic pathways. Further attention to polypharmacy should be given to circulate drugs that could hide pharmacokinetics interactions associated with infections, malignancies, chronic kidney disease, and rejection after organ transplantation.

Keywords: Heart, transplant, immunosuppressive, tacrolimus, detection, cyclosporin, pharmacotherapy.

Graphical Abstract
[1]
Harris, C.; Cao, C.; Croce, B.; Munkholm-Larsen, S. Heart transplantation. Ann. Cardiothorac. Surg., 2018, 7(1), 172.
[http://dx.doi.org/10.21037/acs.2018.01.11] [PMID: 29492396]
[2]
Barnard, C.N. The operation. A human cardiac transplant: An interim report of a successful operation performed at groote schuur hospital, cape town. S. Afr. Med. J., 1967, 41(48), 1271-1274.
[PMID: 4170370]
[3]
Tolou-Ghamari, Z; Mir Mohammad Sadeghi, M; Mazdak, H. Monitoring heart transplant recipients in order to investigate immunosuppressive drug absorption using pharmacokinetics parameters and its’ correlation with nephrotoxicity. AJECR, 2019, 6(4)
[4]
Tolou-Ghamari, Z.; Palizban, A.A.; Michael Tredger, J. Clinical monitoring of tacrolimus after liver transplantation using pentamer formation assay and microparticle enzyme immunoassay. Drugs R D., 2004, 5(1), 17-22.
[http://dx.doi.org/10.2165/00126839-200405010-00003] [PMID: 14725486]
[5]
Kirubakaran, R.; Uster, D.W.; Hennig, S.; Carland, J.E.; Day, R.O.; Wicha, S.G.; Stocker, S.L. Adaptation of a population pharmacokinetic model to inform tacrolimus therapy in heart transplant recipients. Br. J. Clin. Pharmacol., 2023, 89(3), 1162-1175.
[http://dx.doi.org/10.1111/bcp.15566] [PMID: 36239542]
[6]
Regazzi, M.B.; Rinaldi, M.; Molinaro, M.; Pellegrini, C.; Calvi, M.; Arbustini, E.; Bellotti, E.; Bascapè, V.; Martinelli, L.; Viganò, M. Clinical pharmacokinetics of tacrolimus in heart transplant recipients. Ther. Drug Monit., 1999, 21(1), 2-7.
[http://dx.doi.org/10.1097/00007691-199902000-00002] [PMID: 10051048]
[7]
Kalt, D.A. Tacrolimus: A review of laboratory detection methods and indications for use. Lab. Med., 2017, 48(4), e62-e65.
[http://dx.doi.org/10.1093/labmed/lmx056] [PMID: 29096030]
[8]
Yang, X.; Guo, C.; Zhang, M.; Li, Y.; Ren, M.; Mao, S.; Dhakal, R.; Kim, N.Y.; Dong, Z.; Sun, B.; Yao, Z. Ultrahigh-sensitivity multi-parameter tacrolimus solution detection based on an anchor planar millifluidic microwave biosensor. Anal. Methods, 2023, 15(14), 1765-1774.
[http://dx.doi.org/10.1039/D3AY00100H] [PMID: 36880531]
[9]
Huo, Y.; Zhang, S.; Pan, C.; Shan, H.; Xu, Y.; Cai, X. A robust procedure for determination of immunosuppressants cyclosporine a and tacrolimus in blood samples with detection of LC–MS/MS. Chromatographia, 2023, 86(3), 255-263.
[http://dx.doi.org/10.1007/s10337-023-04241-8]
[10]
Huang, Y.; Tang, H.; Meng, X.; Zhong, H.; Song, Y.; Chen, B.; Zou, Z. Rapid and simultaneous determination of two immunosuppressants in whole blood by high performance liquid chromatography. Se Pu, 2023, 41(2), 152-159.
[http://dx.doi.org/10.3724/SP.J.1123.2022.03033]
[11]
Wang, X.; Dai, X.; Wan, S.; Fan, Y.; Wu, L.; Xu, H.; Yan, L.; Gong, X.; Li, Y.; Luo, Y.; Bai, Y.; Li, Y. A volumetric absorptive microsampling uplc-ms/ms method for simultaneous quantification of tacrolimus, mycophenolic acid and creatinine in whole blood of renal transplant recipients. Pharmaceutics, 2022, 14(12), 2547.
[http://dx.doi.org/10.3390/pharmaceutics14122547] [PMID: 36559041]
[12]
Kawai, T.; Mihara, Y.; Morita, M.; Ohkubo, M.; Asami, T.; Watanabe, T.M. Quantitation of cell membrane permeability of cyclic peptides by single: Cell cytoplasm mass spectrometry. Anal. Chem., 2021, 93(7), 3370-3377.
[http://dx.doi.org/10.1021/acs.analchem.0c03901] [PMID: 33550808]
[13]
Lee, Y.W. Comparison between ultra-performance liquid chromatography with tandem mass spectrometry and a chemiluminescence immunoassay in the determination of cyclosporin a and tacrolimus levels in whole blood. Exp. Ther. Med., 2013, 6(6), 1535-1539.
[http://dx.doi.org/10.3892/etm.2013.1325] [PMID: 24255687]
[14]
Tszyrsznic, W.; Borowiec, A.; Pawlowska, E.; Jazwiec, R.; Zochowska, D.; Bartlomiejczyk, I.; Zegarska, J.; Paczek, L.; Dadlez, M. Two rapid ultra performance liquid chromatography/tandem mass spectrometry (uplc/ms/ms) methods with common sample pretreatment for therapeutic drug monitoring of immunosuppressants compared to immunoassay. J. Chromatogr. B Analyt. Technol. Biomed. Life Sci., 2013, 928, 9-15.
[http://dx.doi.org/10.1016/j.jchromb.2013.03.014] [PMID: 23584041]
[15]
Crettol, S.; Venetz, J.P.; Fontana, M.; Aubert, J.D.; Pascual, M.; Eap, C.B. CYP3A7, CYP3A5, CYP3A4, and ABCB1 genetic polymorphisms, cyclosporine concentration, and dose requirement in transplant recipients. Ther. Drug Monit., 2008, 30(6), 689-699.
[http://dx.doi.org/10.1097/FTD.0b013e31818a2a60] [PMID: 18978522]
[16]
Barbarino, J.M.; Staatz, C.E.; Venkataramanan, R.; Klein, T.E.; Altman, R.B. PharmGKB summary. Pharmacogenet. Genomics, 2013, 23(10), 563-585.
[http://dx.doi.org/10.1097/FPC.0b013e328364db84] [PMID: 23922006]
[17]
Tolou-Ghamari, Z. Monitoring tacrolimus after liver transplanatation; a consideration of alternative techniques and the influence of clinical status; King’s College: London, 1999.
[18]
Tolou-Ghamari, Z.; Palizban, A.A.; Tredger, J.M. Modelling tacrolimus auc in acute and chronic liver disease immediately after transplant. transplantationsmedizin. Organ der Deutschen Transplantationsgesellschaft, 2004, 16(2), 109-111.
[19]
Tolou-Ghamari, Z.; Palizban, A.A.; Wendon, J.; Tredger, J.M. Pharmacokinetics of tacrolimus immediately after liver transplantation. transplantationsmedizin. Organ der Deutschen Transplantationsgesellschaft, 2004, 16(2), 112-116.
[20]
Roth, G.A.; Mensah, G.A.; Johnson, C.O.; Addolorato, G.; Ammirati, E.; Baddour, L.M.; Barengo, N.C.; Beaton, A.Z.; Benjamin, E.J.; Benziger, C.P.; Bonny, A.; Brauer, M.; Brodmann, M.; Cahill, T.J.; Carapetis, J.; Catapano, A.L.; Chugh, S.S.; Cooper, L.T.; Coresh, J.; Criqui, M.; DeCleene, N.; Eagle, K.A.; Emmons-Bell, S.; Feigin, V.L.; Fernández-Solà, J.; Fowkes, G.; Gakidou, E.; Grundy, S.M.; He, F.J.; Howard, G.; Hu, F.; Inker, L.; Karthikeyan, G.; Kassebaum, N.; Koroshetz, W.; Lavie, C.; Lloyd-Jones, D.; Lu, H.S.; Mirijello, A.; Temesgen, A.M.; Mokdad, A.; Moran, A.E.; Muntner, P.; Narula, J.; Neal, B.; Ntsekhe, M.; Moraes de Oliveira, G.; Otto, C.; Owolabi, M.; Pratt, M.; Rajagopalan, S.; Reitsma, M.; Ribeiro, A.L.P.; Rigotti, N.; Rodgers, A.; Sable, C.; Shakil, S.; Sliwa-Hahnle, K.; Stark, B.; Sundström, J.; Timpel, P.; Tleyjeh, I.M.; Valgimigli, M.; Vos, T.; Whelton, P.K.; Yacoub, M.; Zuhlke, L.; Murray, C.; Fuster, V.; Roth, G.A.; Mensah, G.A.; Johnson, C.O.; Addolorato, G.; Ammirati, E.; Baddour, L.M.; Barengo, N.C.; Beaton, A.; Benjamin, E.J.; Benziger, C.P.; Bonny, A.; Brauer, M.; Brodmann, M.; Cahill, T.J.; Carapetis, J.R.; Catapano, A.L.; Chugh, S.; Cooper, L.T.; Coresh, J.; Criqui, M.H.; DeCleene, N.K.; Eagle, K.A.; Emmons-Bell, S.; Feigin, V.L.; Fernández-Sola, J.; Fowkes, F.G.R.; Gakidou, E.; Grundy, S.M.; He, F.J.; Howard, G.; Hu, F.; Inker, L.; Karthikeyan, G.; Kassebaum, N.J.; Koroshetz, W.J.; Lavie, C.; Lloyd-Jones, D.; Lu, H.S.; Mirijello, A.; Misganaw, A.T.; Mokdad, A.H.; Moran, A.E.; Muntner, P.; Narula, J.; Neal, B.; Ntsekhe, M.; Oliveira, G.M.M.; Otto, C.M.; Owolabi, M.O.; Pratt, M.; Rajagopalan, S.; Reitsma, M.B.; Ribeiro, A.L.P.; Rigotti, N.A.; Rodgers, A.; Sable, C.A.; Shakil, S.S.; Sliwa, K.; Stark, B.A.; Sundström, J.; Timpel, P.; Tleyjeh, I.I.; Valgimigli, M.; Vos, T.; Whelton, P.K.; Yacoub, M.; Zuhlke, L.J.; Abbasi-Kangevari, M.; Abdi, A.; Abedi, A.; Aboyans, V.; Abrha, W.A.; Abu-Gharbieh, E.; Abushouk, A.I.; Acharya, D.; Adair, T.; Adebayo, O.M.; Ademi, Z.; Advani, S.M.; Afshari, K.; Afshin, A.; Agarwal, G.; Agasthi, P.; Ahmad, S.; Ahmadi, S.; Ahmed, M.B.; Aji, B.; Akalu, Y.; Akande-Sholabi, W.; Aklilu, A.; Akunna, C.J.; Alahdab, F.; Al-Eyadhy, A.; Alhabib, K.F.; Alif, S.M.; Alipour, V.; Aljunid, S.M.; Alla, F.; Almasi-Hashiani, A.; Almustanyir, S.; Al-Raddadi, R.M.; Amegah, A.K.; Amini, S.; Aminorroaya, A.; Amu, H.; Amugsi, D.A.; Ancuceanu, R.; Anderlini, D.; Andrei, T.; Andrei, C.L.; Ansari-Moghaddam, A.; Anteneh, Z.A.; Antonazzo, I.C.; Antony, B.; Anwer, R.; Appiah, L.T.; Arabloo, J.; Ärnlöv, J.; Artanti, K.D.; Ataro, Z.; Ausloos, M.; Avila-Burgos, L.; Awan, A.T.; Awoke, M.A.; Ayele, H.T.; Ayza, M.A.; Azari, S.; B, D.B.; Baheiraei, N.; Baig, A.A.; Bakhtiari, A.; Banach, M.; Banik, P.C.; Baptista, E.A.; Barboza, M.A.; Barua, L.; Basu, S.; Bedi, N.; Béjot, Y.; Bennett, D.A.; Bensenor, I.M.; Berman, A.E.; Bezabih, Y.M.; Bhagavathula, A.S.; Bhaskar, S.; Bhattacharyya, K.; Bijani, A.; Bikbov, B.; Birhanu, M.M.; Boloor, A.; Brant, L.C.; Brenner, H.; Briko, N.I.; Butt, Z.A.; Caetano dos Santos, F.L.; Cahill, L.E.; Cahuana-Hurtado, L.; Cámera, L.A.; Campos-Nonato, I.R.; Cantu-Brito, C.; Car, J.; Carrero, J.J.; Carvalho, F.; Castañeda-Orjuela, C.A.; Catalá-López, F.; Cerin, E.; Charan, J.; Chattu, V.K.; Chen, S.; Chin, K.L.; Choi, J-Y.J.; Chu, D-T.; Chung, S-C.; Cirillo, M.; Coffey, S.; Conti, S.; Costa, V.M.; Cundiff, D.K.; Dadras, O.; Dagnew, B.; Dai, X.; Damasceno, A.A.M.; Dandona, L.; Dandona, R.; Davletov, K.; De la Cruz-Góngora, V.; De la Hoz, F.P.; De Neve, J-W.; Denova-Gutiérrez, E.; Derbew Molla, M.; Derseh, B.T.; Desai, R.; Deuschl, G.; Dharmaratne, S.D.; Dhimal, M.; Dhungana, R.R.; Dianatinasab, M.; Diaz, D.; Djalalinia, S.; Dokova, K.; Douiri, A.; Duncan, B.B.; Duraes, A.R.; Eagan, A.W.; Ebtehaj, S.; Eftekhari, A.; Eftekharzadeh, S.; Ekholuenetale, M.; El Nahas, N.; Elgendy, I.Y.; Elhadi, M.; El-Jaafary, S.I.; Esteghamati, S.; Etisso, A.E.; Eyawo, O.; Fadhil, I.; Faraon, E.J.A.; Faris, P.S.; Farwati, M.; Farzadfar, F.; Fernandes, E.; Fernandez Prendes, C.; Ferrara, P.; Filip, I.; Fischer, F.; Flood, D.; Fukumoto, T.; Gad, M.M.; Gaidhane, S.; Ganji, M.; Garg, J.; Gebre, A.K.; Gebregiorgis, B.G.; Gebregzabiher, K.Z.; Gebremeskel, G.G.; Getacher, L.; Obsa, A.G.; Ghajar, A.; Ghashghaee, A.; Ghith, N.; Giampaoli, S.; Gilani, S.A.; Gill, P.S.; Gillum, R.F.; Glushkova, E.V.; Gnedovskaya, E.V.; Golechha, M.; Gonfa, K.B.; Goudarzian, A.H.; Goulart, A.C.; Guadamuz, J.S.; Guha, A.; Guo, Y.; Gupta, R.; Hachinski, V.; Hafezi-Nejad, N.; Haile, T.G.; Hamadeh, R.R.; Hamidi, S.; Hankey, G.J.; Hargono, A.; Hartono, R.K.; Hashemian, M.; Hashi, A.; Hassan, S.; Hassen, H.Y.; Havmoeller, R.J.; Hay, S.I.; Hayat, K.; Heidari, G.; Herteliu, C.; Holla, R.; Hosseini, M.; Hosseinzadeh, M.; Hostiuc, M.; Hostiuc, S.; Househ, M.; Huang, J.; Humayun, A.; Iavicoli, I.; Ibeneme, C.U.; Ibitoye, S.E.; Ilesanmi, O.S.; Ilic, I.M.; Ilic, M.D.; Iqbal, U.; Irvani, S.S.N.; Islam, S.M.S.; Islam, R.M.; Iso, H.; Iwagami, M.; Jain, V.; Javaheri, T.; Jayapal, S.K.; Jayaram, S.; Jayawardena, R.; Jeemon, P.; Jha, R.P.; Jonas, J.B.; Jonnagaddala, J.; Joukar, F.; Jozwiak, J.J.; Jürisson, M.; Kabir, A.; Kahlon, T.; Kalani, R.; Kalhor, R.; Kamath, A.; Kamel, I.; Kandel, H.; Kandel, A.; Karch, A.; Kasa, A.S.; Katoto, P.D.M.C.; Kayode, G.A.; Khader, Y.S.; Khammarnia, M.; Khan, M.S.; Khan, M.N.; Khan, M.; Khan, E.A.; Khatab, K.; Kibria, G.M.A.; Kim, Y.J.; Kim, G.R.; Kimokoti, R.W.; Kisa, S.; Kisa, A.; Kivimäki, M.; Kolte, D.; Koolivand, A.; Korshunov, V.A.; Koulmane Laxminarayana, S.L.; Koyanagi, A.; Krishan, K.; Krishnamoorthy, V.; Kuate Defo, B.; Kucuk Bicer, B.; Kulkarni, V.; Kumar, G.A.; Kumar, N.; Kurmi, O.P.; Kusuma, D.; Kwan, G.F.; La Vecchia, C.; Lacey, B.; Lallukka, T.; Lan, Q.; Lasrado, S.; Lassi, Z.S.; Lauriola, P.; Lawrence, W.R.; Laxmaiah, A.; LeGrand, K.E.; Li, M-C.; Li, B.; Li, S.; Lim, S.S.; Lim, L-L.; Lin, H.; Lin, Z.; Lin, R-T.; Liu, X.; Lopez, A.D.; Lorkowski, S.; Lotufo, P.A.; Lugo, A.; M, N.K.; Madotto, F.; Mahmoudi, M.; Majeed, A.; Malekzadeh, R.; Malik, A.A.; Mamun, A.A.; Manafi, N.; Mansournia, M.A.; Mantovani, L.G.; Martini, S.; Mathur, M.R.; Mazzaglia, G.; Mehata, S.; Mehndiratta, M.M.; Meier, T.; Menezes, R.G.; Meretoja, A.; Mestrovic, T.; Miazgowski, B.; Miazgowski, T.; Michalek, I.M.; Miller, T.R.; Mirrakhimov, E.M.; Mirzaei, H.; Moazen, B.; Moghadaszadeh, M.; Mohammad, Y.; Mohammad, D.K.; Mohammed, S.; Mohammed, M.A.; Mokhayeri, Y.; Molokhia, M.; Montasir, A.A.; Moradi, G.; Moradzadeh, R.; Moraga, P.; Morawska, L.; Moreno Velásquez, I.; Morze, J.; Mubarik, S.; Muruet, W.; Musa, K.I.; Nagarajan, A.J.; Nalini, M.; Nangia, V.; Naqvi, A.A.; Narasimha Swamy, S.; Nascimento, B.R.; Nayak, V.C.; Nazari, J.; Nazarzadeh, M.; Negoi, R.I.; Neupane Kandel, S.; Nguyen, H.L.T.; Nixon, M.R.; Norrving, B.; Noubiap, J.J.; Nouthe, B.E.; Nowak, C.; Odukoya, O.O.; Ogbo, F.A.; Olagunju, A.T.; Orru, H.; Ortiz, A.; Ostroff, S.M.; Padubidri, J.R.; Palladino, R.; Pana, A.; Panda-Jonas, S.; Parekh, U.; Park, E-C.; Parvizi, M.; Pashazadeh Kan, F.; Patel, U.K.; Pathak, M.; Paudel, R.; Pepito, V.C.F.; Perianayagam, A.; Perico, N.; Pham, H.Q.; Pilgrim, T.; Piradov, M.A.; Pishgar, F.; Podder, V.; Polibin, R.V.; Pourshams, A.; Pribadi, D.R.A.; Rabiee, N.; Rabiee, M.; Radfar, A.; Rafiei, A.; Rahim, F.; Rahimi-Movaghar, V.; Ur Rahman, M.H.; Rahman, M.A.; Rahmani, A.M.; Rakovac, I.; Ram, P.; Ramalingam, S.; Rana, J.; Ranasinghe, P.; Rao, S.J.; Rathi, P.; Rawal, L.; Rawasia, W.F.; Rawassizadeh, R.; Remuzzi, G.; Renzaho, A.M.N.; Rezapour, A.; Riahi, S.M.; Roberts-Thomson, R.L.; Roever, L.; Rohloff, P.; Romoli, M.; Roshandel, G.; Rwegerera, G.M.; Saadatagah, S.; Saber-Ayad, M.M.; Sabour, S.; Sacco, S.; Sadeghi, M.; Saeedi Moghaddam, S.; Safari, S.; Sahebkar, A.; Salehi, S.; Salimzadeh, H.; Samaei, M.; Samy, A.M.; Santos, I.S.; Santric-Milicevic, M.M.; Sarrafzadegan, N.; Sarveazad, A.; Sathish, T.; Sawhney, M.; Saylan, M.; Schmidt, M.I.; Schutte, A.E.; Senthilkumaran, S.; Sepanlou, S.G.; Sha, F.; Shahabi, S.; Shahid, I.; Shaikh, M.A.; Shamali, M.; Shamsizadeh, M.; Shawon, M.S.R.; Sheikh, A.; Shigematsu, M.; Shin, M-J.; Shin, J.I.; Shiri, R.; Shiue, I.; Shuval, K.; Siabani, S.; Siddiqi, T.J.; Silva, D.A.S.; Singh, J.A.; Mtech, A.S.; Skryabin, V.Y.; Skryabina, A.A.; Soheili, A.; Spurlock, E.E.; Stockfelt, L.; Stortecky, S.; Stranges, S.; Suliankatchi Abdulkader, R.; Tadbiri, H.; Tadesse, E.G.; Tadesse, D.B.; Tajdini, M.; Tariqujjaman, M.; Teklehaimanot, B.F.; Temsah, M-H.; Tesema, A.K.; Thakur, B.; Thankappan, K.R.; Thapar, R.; Thrift, A.G.; Timalsina, B.; Tonelli, M.; Touvier, M.; Tovani-Palone, M.R.; Tripathi, A.; Tripathy, J.P.; Truelsen, T.C.; Tsegay, G.M.; Tsegaye, G.W.; Tsilimparis, N.; Tusa, B.S.; Tyrovolas, S.; Umapathi, K.K.; Unim, B.; Unnikrishnan, B.; Usman, M.S.; Vaduganathan, M.; Valdez, P.R.; Vasankari, T.J.; Velazquez, D.Z.; Venketasubramanian, N.; Vu, G.T.; Vujcic, I.S.; Waheed, Y.; Wang, Y.; Wang, F.; Wei, J.; Weintraub, R.G.; Weldemariam, A.H.; Westerman, R.; Winkler, A.S.; Wiysonge, C.S.; Wolfe, C.D.A.; Wubishet, B.L.; Xu, G.; Yadollahpour, A.; Yamagishi, K.; Yan, L.L.; Yandrapalli, S.; Yano, Y.; Yatsuya, H.; Yeheyis, T.Y.; Yeshaw, Y.; Yilgwan, C.S.; Yonemoto, N.; Yu, C.; Yusefzadeh, H.; Zachariah, G.; Zaman, S.B.; Zaman, M.S.; Zamanian, M.; Zand, R.; Zandifar, A.; Zarghi, A.; Zastrozhin, M.S.; Zastrozhina, A.; Zhang, Z-J.; Zhang, Y.; Zhang, W.; Zhong, C.; Zou, Z.; Zuniga, Y.M.H.; Murray, C.J.L.; Fuster, V. Global burden of cardiovascular diseases and risk factors, 1990–2019. J. Am. Coll. Cardiol., 2020, 76(25), 2982-3021.
[http://dx.doi.org/10.1016/j.jacc.2020.11.010] [PMID: 33309175]
[21]
Maaike, A.; Sikma, M.A.; Hunault, C.C.; Kirkels, J.H.; Verhaar, M.C.; Kesecioglu, J.; de Lange, D.W. Association of whole blood tacrolimus concentrations with kidney injury in heart transplantation patients. Eur. J. Drug Metab. Pharmacokinet., 2018, 43(3), 311-320.
[PMID: 29236211]
[22]
Morizawa, Y.; Satoh, H.; Arai, M.; Iwasa, S.; Sato, A.; Fujimoto, K. Association between nonadherence and transient hyperuricemia in pediatric kidney transplantation. Transplant. Proc., 2023, 55(1), 129-133.
[http://dx.doi.org/10.1016/j.transproceed.2022.09.033] [PMID: 36581508]
[23]
Bansal, N.; Everitt, M.D.; Nandi, D.; Spinner, J.; Conway, J.; Magnetta, D.A.; Profita, E.L.; Townsend, M.; Alejos, J.C.; Deshpande, S.R. Clinical approach to acute cellular rejection from the pediatric heart transplant society. Pediatr. Transplant., 2022, 26(8), e14393.
[http://dx.doi.org/10.1111/petr.14393] [PMID: 36377327]
[24]
Balcerac, A.; Bihan, K.; Psimaras, D.; Lebrun-Vignes, B.; Salem, J.E.; Weiss, N. Drugs associated with posterior reversible encephalopathy syndrome, a worldwide signal detection study. J. Neurol., 2023, 270(2), 975-985.
[http://dx.doi.org/10.1007/s00415-022-11450-y] [PMID: 36329183]
[25]
Coste, G.; Chabanne, C.; Tron, C.; Lelong, B.; Verdier, M.C.; Roussel, M.; Le Gall, F.; Turlin, B.; Desille-Dugast, M.; Flécher, E.; Laviolle, B.; Lemaitre, F. Blood, cellular, and tissular calcineurin inhibitors pharmacokinetic–pharmacodynamic relationship in heart transplant recipients: The INTRACAR study. Ther. Drug Monit., 2023, 45(2), 229-235.
[http://dx.doi.org/10.1097/FTD.0000000000001025] [PMID: 36006706]
[26]
Söderlund, C.; Rådegran, G. Immunosuppressive therapies after heart transplantation: The balance between under- and over-immunosuppression. Transplant. Rev., 2015, 29(3), 181-189.
[http://dx.doi.org/10.1016/j.trre.2015.02.005] [PMID: 25812489]
[27]
Kim, I.C.; Youn, J.C.; Kobashigawa, J.A.; Kobashigawa, J.A. The past, present and future of heart transplantation. Korean Circ. J., 2018, 48(7), 565-590.
[http://dx.doi.org/10.4070/kcj.2018.0189] [PMID: 29968430]
[28]
Blanca Martínez Pérez, A.; López Suárez, A.; Rodríguez Rodríguez, J.; Sobrino Márquez, J.M.; Lage Gallé, E. Medication adherence in patients who undergo cardiac transplantation. Transplant. Proc., 2013, 45(10), 3662-3664.
[http://dx.doi.org/10.1016/j.transproceed.2013.11.006] [PMID: 24314989]
[29]
Masoudi, F.A.; Krumholz, H.M. Polypharmacy and comorbidity in heart failure. BMJ, 2003, 327(7414), 513-514.
[http://dx.doi.org/10.1136/bmj.327.7414.513] [PMID: 12958085]
[30]
Yang, F.C.; Chen, H.M.; Huang, C.M.; Hsieh, P.L.; Wang, S.S.; Chen, C.M. The difficulties and needs of organ transplant recipients during postoperative care at home: A systematic review. Int. J. Environ. Res. Public Health, 2020, 17(16), 5798.
[http://dx.doi.org/10.3390/ijerph17165798] [PMID: 32796529]
[31]
Peretz, D.; On, N.H.; Miller, D.; Kim, R.; Franklin, C.; Dascal, R.; Knowles, C.; Minuk, G.Y. Pharmacokinetics of a once‐daily tacrolimus formulation in first nations and caucasian liver transplant recipients. Transpl. Int., 2021, 34(11), 2266-2273.
[http://dx.doi.org/10.1111/tri.13997] [PMID: 34318518]
[32]
Li, Y.; Jing, Q.; Wang, B.; Wang, X.; Li, J.; Qiao, S.; Chen, S.; Angiolillo, D.J.; Han, Y. Extended antiplatelet therapy with clopidogrel alone versus clopidogrel plus aspirin after completion of 9- to 12-month dual antiplatelet therapy for acute coronary syndrome patients with both high bleeding and ischemic risk. rationale and design of the opt-birisk double-blinded, placebo-controlled randomized trial. Am. Heart J., 2020, 228, 1-7.
[http://dx.doi.org/10.1016/j.ahj.2020.07.005] [PMID: 32739652]
[33]
Zhou, Z.X.; Yin, X.D.; Zhang, Y.; Shao, Q.H.; Mao, X.Y.; Hu, W.J.; Shen, Y.L.; Zhao, B.; Li, Z.L. Antifungal drugs and drug-induced liver injury: A real-world study leveraging the fda adverse event reporting system database. Front. Pharmacol., 2022, 13, 891336.
[http://dx.doi.org/10.3389/fphar.2022.891336] [PMID: 35571077]
[34]
Kofla, G.; Ruhnke, M. Pharmacology and metabolism of anidulafungin, caspofungin and micafungin in the treatment of invasive candidosis:Review of the literature. Eur. J. Med. Res., 2011, 16(4), 159-166.
[http://dx.doi.org/10.1186/2047-783X-16-4-159] [PMID: 21486730]
[35]
Dhar, R. Neurologic complications of transplantation. Neurocrit. Care, 2018, 28(1), 4-11.
[http://dx.doi.org/10.1007/s12028-017-0387-6] [PMID: 28251577]
[36]
Robert, L.; PageII, R.L.; Miller, G.G.; Lindenfeld, J.; Geraldine, G. Drug therapy in the heart transplant recipient. Circulation, 2005, 111, 230-239.
[37]
Rivinius, R.; Helmschrott, M.; Rahm, A.K.; Darche, F.F.; Thomas, D.; Bruckner, T.; Doesch, A.O.; Ehlermann, P.; Katus, H.A.; Zitron, E. Combined amiodarone and digitalis therapy before heart transplantation is associated with increased post‐transplant mortality. ESC Heart Fail., 2020, 7(5), 2082-2092.
[http://dx.doi.org/10.1002/ehf2.12807] [PMID: 32608191]
[38]
Cheng, C.W.; Hendrickson, J.E.; Tormey, C.A.; Davinder Sidhu, D. Therapeutic plasma exchange and its impact on drug levels: An aclps critical review. Am J Clin Pathol, 2017, 148(3), 190-198.
[http://dx.doi.org/10.1093/ajcp/aqx056]
[39]
Shepard, P.W.; St Louis, E.K. Seizure treatment in transplant patients. Curr. Treat. Options Neurol., 2012, 14(4), 332-347.
[http://dx.doi.org/10.1007/s11940-012-0180-y] [PMID: 22660960]
[40]
Sawhney, H.; Gill, S.S. Renal transplant recipient seizure practical management. World J. Nephrol., 2020, 9(1), 1-8.
[http://dx.doi.org/10.5527/wjn.v9.i1.1] [PMID: 32742951]
[41]
Jantz, A.S.; Patel, S.J.; Suki, W.N.; Knight, R.J.; Bhimaraj, A.; Gaber, A.O. Treatment of acute tacrolimus toxicity with phenytoin in solid organ transplant recipients. Case Rep. Transplant., 2013, 2013, 1-6.
[http://dx.doi.org/10.1155/2013/375263] [PMID: 23844312]
[42]
Beezer, J.; Al Hatrushi, M.; Husband, A.; Kurdi, A.; Forsyth, P. Polypharmacy definition and prevalence in heart failure: A systematic review. Heart Fail. Rev., 2022, 27(2), 465-492.
[http://dx.doi.org/10.1007/s10741-021-10135-4] [PMID: 34213753]
[43]
Ahmadian, E.; Zununi Vahed, S.; Mammadova, S.; Abediazar, S. Immunosuppressant management in renal transplant patients with COVID-19. BioMed Res. Int., 2021, 2021, 1-8.
[http://dx.doi.org/10.1155/2021/9318725] [PMID: 34692845]
[44]
Oomen, L.; Bootsma-Robroeks, C.; Cornelissen, E.; Wall, L.; Feitz, W. Pearls and pitfalls in pediatric kidney transplantation after 5 decades. Front Pediatr., 2022, 10, 856630.
[http://dx.doi.org/10.3389/fped.2022.856630] [PMID: 35463874]
[45]
Tolou-Ghamari, Z.; Palizban, A.; Gharavi, M. Cyclosporin trough concentration-rejection relationship after kidney transplantation. Indian J. Pharmacol., 2003, 35(6), 395-396.
[46]
Tolou-Ghamari, Z.; Mortazavi, M.; Palizban, A.A.; Najafi, M.R. The investigation of correlation between iminoral concentration and neurotoxic levels after kidney transplantation. Adv. Biomed. Res., 2015, 4.
[http://dx.doi.org/10.4103/2277-9175.151876]
[47]
Tolou-Ghamari, Z; Sanei, B Prograf concentrations in liver transplantation: Correlation with headache and other neurotoxic complications. Thrita, 2016, 5(1)
[48]
Tolou-Ghamari, Z.; Palizban, A.A. Laboratory monitoring of cyclosporine pre-dose concentration (c 0) after kidney transplantation in isfahan. IJMS, 2003, 28(2), 81-85.
[49]
Kniepeiss, D.; Renner, W.; Trummer, O.; Wagner, D.; Wasler, A.; Khoschsorur, G.A.; Truschnig-Wilders, M.; Tscheliessnigg, K.H. The role of CYP3A5 genotypes in dose requirements of tacrolimus and everolimus after heart transplantation. Clin. Transplant., 2011, 25(1), 146-150.
[http://dx.doi.org/10.1111/j.1399-0012.2009.01198.x] [PMID: 20041908]
[50]
Patel, J.K.; Kobashigawa, J.A. Tacrolimus in heart transplant recipients: An overview. BioDrugs, 2007, 21(3), 139-143.
[http://dx.doi.org/10.2165/00063030-200721030-00001] [PMID: 17516709]
[51]
McCormack, P.L.; Keating, G.M. Tacrolimus. Drugs, 2006, 66(17), 2269-2279.
[http://dx.doi.org/10.2165/00003495-200666170-00010] [PMID: 17137409]
[52]
Gijsen, V.; Mital, S.; van Schaik, R.H.; Soldin, O.P.; Soldin, S.J.; van der Heiden, I.P.; Nulman, I.; Koren, G.; de Wildt, S.N. Age and CYP3A5 genotype affect tacrolimus dosing requirements after transplant in pediatric heart recipients. J. Heart Lung Transplant., 2011, 30(12), 1352-1359.
[http://dx.doi.org/10.1016/j.healun.2011.08.001] [PMID: 21930396]
[53]
van Gelder, T.; Balk, A.H.; Zietse, R.; Hesse, C.; Mochtar, B.; Weimar, W. Renal insufficiency after heart transplantation: A case-control study. Nephrol. Dial. Transplant., 1998, 13(9), 2322-2326.
[http://dx.doi.org/10.1093/ndt/13.9.2322] [PMID: 9761516]
[54]
Jia, Y.; Meng, X.; Li, Y.; Xu, C.; Zeng, W.; Jiao, Y.; Han, W. Optimal sampling time point for cyclosporin a concentration monitoring in heart transplant recipients. Exp. Ther. Med., 2018, 16(5), 4265-4270.
[http://dx.doi.org/10.3892/etm.2018.6711] [PMID: 30402164]
[55]
Katada, Y.; Nakagawa, S.; Itohara, K.; Suzuki, T.; Kato, R.; Endo, H. Association between time in therapeutic range of tacrolimus blood concentration and acute rejection within the first three months after lung transplantation. J. Pharm. Health Care Sci., 2022, 8(1), 25.
[http://dx.doi.org/10.1186/s40780-022-00256-9]
[56]
De Gregori, S.; De Silvestri, A.; Cattadori, B.; Rapagnani, A.; Albertini, R.; Novello, E. Therapeutic drug monitoring of tacrolimus-personalized therapy in heart transplantation: New strategies and preliminary results in endomyocardial biopsies. Pharmaceutics, 2022, 14(6), 1247.
[http://dx.doi.org/10.3390/pharmaceutics14061247]
[57]
Toro-Trujillo, E.; Garcia, E.; Garcia-Peña, A.A.; Muñoz-Velandia, O.M.; Mariño, A. Factors related to the acute cellular rejection during the first year after heart transplant. Transplant. Proc., 2018, 50(10), 3715-3719.
[http://dx.doi.org/10.1016/j.transproceed.2018.08.041] [PMID: 30577261]
[58]
Grimm, M.; Rinaldi, M.; Yonan, N.A.; Arpesella, G.; Arizón Del Prado, J.M.; Pulpón, L.A.; Villemot, J.P.; Frigerio, M.; Rodriguez Lambert, J.L.; Crespo-Leiro, M.G.; Almenar, L.; Duveau, D.; Ordonez-Fernandez, A.; Gandjbakhch, J.; Maccherini, M.; Laufer, G. Superior prevention of acute rejection by tacrolimus vs. cyclosporine in heart transplant recipients-a large european trial. Am. J. Transplant., 2006, 6(6), 1387-1397.
[http://dx.doi.org/10.1111/j.1600-6143.2006.01300.x] [PMID: 16686762]
[59]
Tonsho, M.; Michel, S.; Ahmed, Z.; Alessandrini, A.; Madsen, J.C. Heart transplantation: Challenges facing the field. Cold Spring Harb. Perspect. Med., 2014, 4(5), a015636.
[http://dx.doi.org/10.1101/cshperspect.a015636] [PMID: 24789875]
[60]
Doesch, A.; Helmschrott, M.; Beckendorf, J.; Akyol, C.; Ruhparwar, A.; Schmack, B.; Erbel, C.; Gleissner, C.; Akhavanpoor, M.; Ehlermann, P.; Bruckner, T.; Katus, H. Superior rejection profile during the first 24 months after heart transplantation under tacrolimus as baseline immunosuppressive regimen. Drug Des. Devel. Ther., 2014, 8, 1307-1314.
[http://dx.doi.org/10.2147/DDDT.S68542] [PMID: 25246772]
[61]
Peled, Y.; Lavee, J.; Arad, M.; Shemesh, Y.; Katz, M.; Kassif, Y.; Asher, E.; Elian, D.; Har-Zahav, Y.; Goldenberg, I.; Freimark, D. The impact of gender mismatching on early and late outcomes following heart transplantation. ESC Heart Fail., 2017, 4(1), 31-39.
[http://dx.doi.org/10.1002/ehf2.12107] [PMID: 28217310]
[62]
Gupta, T.; Krim, S.R. Cardiac transplantation: Update on a road less traveled. Ochsner J., 2019, 19(4), 369-377.
[http://dx.doi.org/10.31486/toj.19.0022] [PMID: 31903061]
[63]
Bifulco, O.; Bottio, T.; Caraffa, R.; Carrozzini, M.; Guariento, A.; Bejko, J.; Fedrigo, M.; Castellani, C.; Toscano, G.; Lorenzoni, G.; Tarzia, V.; Gregori, D.; Cardillo, M.; Puoti, F.; Feltrin, G.; Angelini, A.; Gerosa, G. Marginal versus standard donors in heart transplantation: Proper selection means heart transplant benefit. J. Clin. Med., 2022, 11(9), 2665.
[http://dx.doi.org/10.3390/jcm11092665] [PMID: 35566789]
[64]
Fujita, R.; Takabayashi, K.; Iwatsu, K.; Matsumura, K.; Ikeda, T.; Kitaguchi, S.; Nohara, R. P6360Prognostic value of polypharmacy in patients with heart failure. Eur. Heart J., 2019, 40(1)(1), ehz746.0956.
[http://dx.doi.org/10.1093/eurheartj/ehz746.0956]
[65]
Gomis-Pastor, M.; Mirabet, S.; Roig, E.; Lopez, L.; Brossa, V.; Galvez-Tugas, E.; Rodriguez-Murphy, E.; Feliu, A.; Ontiveros, G.; Garcia-Cuyàs, F.; Salazar, A.; Mangues, M.A. Interdisciplinary mobile health model to improve clinical care after heart transplantation: Implementation strategy study. JMIR Cardio, 2020, 4(1), e19065.
[http://dx.doi.org/10.2196/19065] [PMID: 33231557]

Rights & Permissions Print Cite
© 2024 Bentham Science Publishers | Privacy Policy